4
Views
0
CrossRef citations to date
0
Altmetric
Research

Patent Evaluation Anti-infectives: Glycopeptide antibiotic derivatives active against Vancomycin-resistant Gram-positive bacteria

Pages 73-75 | Published online: 29 Feb 2008

References

  • Glycopeptide Antibiotics, Nagarajan R (Ed.), Marcel Dekker, Inc., New York (1994).
  • ZECKEL ML, WOODWORTH JR: Vancomycin: a clinical overview. In: Glycopeptide Antibiotics, Nagarajan R (Ed.), Marcel Dekker, Inc., New York (1994):309–409.
  • GOLDSTEIN B, ROSINA R, PARENTI F: Teicoplanin. In: Glycopeptide Antibiotics, Nagarajan R (Ed.), Marcel Dekker, Inc., New York (1994):273–307.
  • SPELLER DCE, LYNN WA, ROGERS TR: Glycopeptide resis-tance in Gram-positive bacteria. Clin. Microbiol. Infect. (1995) 1:54–59.
  • NICAS TI, ALLEN NE: Resistance and mode of action. In: Glycopeptide Antibiotics, Nagarajan R (Ed.), Marcel Dekker, Inc., New York (1994):219–241.
  • NICAS TI: Activity of novel semi-synthetic glycopeptides against Vancomycin-resistant enterococcL Program Abstr. 7th Eur. Cong. Clin. Micro biol. Infect. Dis. (1995) Abstr. 560.
  • NICAS TI et al.: Semisynthetic glycopeptides activeagainst Vancomycin-resistant enterococci: activity against staphylococci and streptococci in vitro and in vivo. Program Abstr. 35th Intersc. Conf Antimicrob. Agents Chemother: Abstr. F248.
  • BOYLAN CJ etal.: Efficacy of semisynthetic glycopeptideactive against Vancomycin-resistant enterococci in a mouse infection model Program Abstr. 35th Intersc. Conf Antimicrob. Agents Chemother : Abstr. F255.
  • BUGG TDH et al.: Molecular basis for Vancomycin resis-tance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by Van-comycin-resistance proteins VanH and VanA. Biochem-istty (1991) 30:10408–10415.
  • WOODFORD NjOHNSON A: Glycopeptide resistance in Gram-positive bacteria: from black and white to shades of grey. J. Med. Microbiol. (1994) 40:375–378.
  • LETOURNEAU DL, HOBBS JN, ALLEN NE: Molecular inter-actions of LY264826 and its p-chlorobenzyl derivative, LY19114S, with dipeptidyl and depsipeptidyl ligands. Program Abstr. 35th Intersc. Conf. Antimictrob. Agents Chemother: Abstr. F251.
  • ZECKEL ML, WOODWORTH JR: Vancomycin safety. In:Glycopeptide Antibiotics, Nagarajan R (Ed.), Marcel Dekker, Inc., New York (1994):219–241.
  • NICAS TI et al.: Semisynthetic glycopeptides active against Vancomycin-resistant enterococci: in vitro ac-tivity against enterococci. Program Abstr. 35th Intersc. Conf Antimicrob. Agents Chemother: Abstr. F249.
  • LIN Y etal.: Non-clinical pharmacokinetics of LY333328, a semisynthetic glycopeptide antibiotic active against vancomycin-resistant enterococcL Program Abstr. 35th Intersc. Conf Antimicrob. Agents Chemother: Abstr, F254.
  • MALABARBA A et al.: Amides of de-acetylglucosaminyl-deoxy Teicoplanin active against highly glycopeptide resistant enterococci. I Antibiot. (1994) 47:1493–1506.
  • MALABARBA A etal.: New semisynthetic glycopeptides MDL63, 246 and MDL63, 042 and other amide derivatives of antibiotic A-40,926 active against highly glycopeptide resistant VanA enterococci j Antibiot. 48:869–883.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.